Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.
about
Richter transformation of CLL.Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly.Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies.How we treat Richter syndrome.A systematic review on Richter syndrome: what is the published evidence?Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.An update for Richter syndrome - new directions and developments.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Richter Syndrome in Chronic Lymphocytic Leukemia.NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study.Ibrutinib has some activity in Richter's syndromeA single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.Treatment of Richter's Syndrome.Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
P2860
Q30249283-0CBD3AAE-5B4B-498B-A010-3638FC47731FQ33343495-6FFBF24D-5BB5-49F5-83AE-A6863A0F8141Q33347439-942B94F2-AF49-4B79-A6CA-1B5F3945BEBDQ35086905-1BFBD99A-5502-4BC2-8576-EC5AC2A8767CQ35994909-4FF4F91E-08C2-434D-95D6-12F8AE76D202Q37636962-A6AFF53E-51A1-4CFD-8B61-29AFEB62F54EQ37676244-2B1D7FE7-0D19-4984-B950-D4D0D1AA6719Q38263924-24E6B1AC-B7ED-4E1F-9530-33486C2B02C3Q38691261-FF1A12DA-AAB5-47C8-B0DB-01702792F8EAQ38896306-4F9D545E-BB45-471E-9DB6-C313885C168BQ40037434-5F23B5EC-0731-455C-84A6-F3795B7ABCFDQ40098409-C7290FD3-A4D7-48AD-8B14-D17FAD432609Q40955026-7AB04A2A-A923-4B73-BF68-9CAD8C6F46ECQ41682806-D6D6DB05-8BFE-46C2-BC39-F4E054BC0707Q42358968-9115C988-B5ED-47F7-859E-128FEB54BD36Q48204203-5CD6EC20-A64B-4CFE-9C27-7B76B4E0B15AQ48204606-E34F8A20-9CE0-4FA9-808C-1C4D651B4387Q49843910-CEAB2EA1-8D24-4238-8E55-90A854F2D2D1Q50074012-AED84B8B-B347-432E-BD74-85589EF25ACB
P2860
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Fractionated cyclophosphamide, ...... regimen in Richter's syndrome.
@en
type
label
Fractionated cyclophosphamide, ...... regimen in Richter's syndrome.
@en
prefLabel
Fractionated cyclophosphamide, ...... regimen in Richter's syndrome.
@en
P2093
P2860
P1433
P1476
Fractionated cyclophosphamide, ...... regimen in Richter's syndrome.
@en
P2093
Kantarjian HM
Keating MJ
O'Brien SM
Schlette ES
P2860
P304
P356
10.3109/10428190109064589
P577
2001-07-01T00:00:00Z